• LAST PRICE
    23.7100
  • TODAY'S CHANGE (%)
    Trending Up1.0000 (4.4033%)
  • Bid / Lots
    23.5200/ 8
  • Ask / Lots
    23.7900/ 4
  • Open / Previous Close
    22.7000 / 22.7100
  • Day Range
    Low 22.5400
    High 24.5000
  • 52 Week Range
    Low 12.5400
    High 28.6701
  • Volume
    274,332
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 22.71
TimeVolumeBCYC
09:32 ET60122.7
09:39 ET75022.6
09:42 ET20022.84
09:48 ET10022.56
09:51 ET30022.65
09:53 ET100022.63
09:55 ET10022.66
09:57 ET30022.55
10:00 ET20022.64
10:02 ET10022.73
10:08 ET22522.7482
10:09 ET10022.82
10:11 ET33022.84
10:13 ET20022.88
10:18 ET21022.91
10:20 ET30022.9059
10:22 ET10023.04
10:26 ET10023.12
10:27 ET20023.21
10:29 ET10023.19
10:31 ET50623.1
10:33 ET91023.22
10:36 ET466923.235
10:38 ET30023.25
10:42 ET10023.47
10:44 ET20023.465
10:45 ET100023.54
10:47 ET20023.64
10:49 ET70023.62
10:51 ET20023.61
10:54 ET10023.63
10:56 ET10023.64
10:58 ET10023.52
11:00 ET180023.51
11:02 ET10023.61
11:03 ET20023.62
11:05 ET10023.6
11:09 ET30023.63
11:14 ET163923.66
11:20 ET20023.76
11:21 ET10023.64
11:23 ET30023.64
11:27 ET158223.5
11:30 ET30023.46
11:32 ET96223.29
11:34 ET20023.375
11:36 ET50023.29
11:39 ET60223.27
11:41 ET30023.24
11:48 ET10023.32
11:50 ET20023.36
11:52 ET105123.49
11:54 ET10023.405
11:56 ET29323.5
11:57 ET10023.49
11:59 ET10023.405
12:03 ET12423.405
12:06 ET20023.405
12:12 ET20023.49
12:14 ET394523.41
12:15 ET40023.47
12:17 ET24523.45
12:19 ET410923.33
12:24 ET180023.535
12:26 ET30023.64
12:28 ET90023.7
12:30 ET20023.665
12:32 ET20023.665
12:33 ET10023.665
12:35 ET70023.605
12:39 ET20023.61
12:44 ET100023.655
12:46 ET33023.73
12:50 ET174123.62
12:53 ET58723.615
12:55 ET20023.61
12:57 ET111823.55
01:00 ET10023.515
01:02 ET20023.505
01:04 ET60023.5
01:08 ET50023.495
01:09 ET20023.47
01:11 ET20023.475
01:15 ET183523.45
01:18 ET120023.49
01:20 ET60023.5
01:22 ET60023.54
01:26 ET27423.54
01:27 ET20023.54
01:31 ET120023.45
01:38 ET10023.465
01:42 ET10023.465
01:44 ET40023.44
01:56 ET10023.53
01:58 ET140023.475
02:00 ET120023.475
02:02 ET280023.415
02:03 ET90023.395
02:05 ET100023.395
02:07 ET190023.55
02:12 ET10023.61
02:14 ET90023.545
02:16 ET90023.52
02:18 ET150023.5
02:20 ET110023.505
02:21 ET110023.5
02:23 ET140023.44
02:25 ET150023.56
02:27 ET10023.61
02:30 ET80023.54
02:34 ET52023.62
02:38 ET35023.56
02:43 ET104723.52
02:45 ET10023.46
02:48 ET950023.515
02:50 ET89723.545
02:52 ET30023.68
02:54 ET20023.75
02:56 ET459523.82
02:57 ET94823.82
02:59 ET515423.94
03:01 ET1020323.675
03:03 ET3246423.86
03:06 ET48824.125
03:08 ET120023.9
03:10 ET80023.9
03:14 ET220023.985
03:15 ET40023.95
03:19 ET65424.025
03:21 ET30024.055
03:24 ET61824.05
03:26 ET91423.91
03:30 ET90024.08
03:32 ET657324
03:33 ET51023.98
03:35 ET54223.905
03:37 ET60023.88
03:39 ET83023.9
03:42 ET4633023.76
03:44 ET97323.81
03:46 ET100023.865
03:48 ET20023.865
03:50 ET20023.845
03:51 ET430123.655
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBCYC
Bicycle Therapeutics PLC
1.6B
-7.2x
---
United StatesNAMS
NewAmsterdam Pharma Company NV
1.6B
-6.9x
---
United StatesNTLA
Intellia Therapeutics Inc
1.5B
-2.8x
---
United StatesRCKT
Rocket Pharmaceuticals Inc
1.5B
-6.1x
---
United StatesSNDX
Syndax Pharmaceuticals Inc
1.6B
-5.6x
---
United StatesSPRY
ARS Pharmaceuticals Inc
1.5B
-32.9x
---
As of 2024-11-04

Company Information

Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. The Company is evaluating BT8009, a Bicycle Toxin Conjugate (BTC) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC targeting EphA2, a historically undruggable target, and BT7480, a Bicycle Tumor-Targeted Immune Cell Agonist (Bicycle TICA) targeting Nectin-4 and agonizing CD137, in Company-sponsored clinical trials. Additionally, the Company is developing Bicycle Radio Conjugates (BRC) for radiopharmaceutical use and, through various partnerships, is exploring the use of Bicycle technology to develop therapies for diseases beyond oncology. Its product candidates also include BT1718 and BT7455.

Contact Information

Headquarters
Blocks A & B, Portway Building, Granta PCAMBRIDGE, United Kingdom CB21 6GS
Phone
122-326-1503
Fax
---

Executives

Non-Executive Chairman of the Board
Pierre Legault
Chief Executive Officer, Executive Director
Kevin Lee
Chief Financial Officer, Principal Financial Officer
Alethia Young
Chief Operating Officer
Alistair Milnes
Chief Technology Officer
Michael Skynner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6B
Revenue (TTM)
$36.9M
Shares Outstanding
69.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.91
EPS
$-3.28
Book Value
$8.74
P/E Ratio
-7.2x
Price/Sales (TTM)
42.5
Price/Cash Flow (TTM)
---
Operating Margin
-534.98%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.